Skip to main content

#162067

Anti-PD1 canine [PD1-1.1]

Cat. #162067

Anti-PD1 canine [PD1-1.1]

Cat. #: 162067

Sub-type: Primary antibody

Availability: 3-4 weeks

Target: canine PD1

Class: Monoclonal

Reactivity: Dog

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Moravian Biotechnology

Tool Details
Target Details
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-PD1 canine [PD1-1.1]
  • Clone: PD1-1.1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: Predicted 17.7 kDa in non-glycosilated form
  • Reactivity: Dog
  • Host: Mouse
  • Description: Antibody created to detect canine PD-1.
  • Immunogen: Canine PD1 protein with HIS tag on N-terminus (6xHIS tag recombinant canine PD-1)
  • Isotype: IgG2a kappa
  • Production details: B Cell donor: Splenocytes from mouse immunised with PD1 protein hiss tagged on N-terminus. Fusion partner: SP2

Target Details

  • Target: canine PD1
  • Molecular weight: Predicted 17.7 kDa in non-glycosilated form
  • Target background: Programmed cell death protein 1, also known as PD-1 and CD279 (cluster of differentiation 279), is a protein on the surface of T and B cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self-tolerance by suppressing T cell inflammatory activity. This prevents autoimmune diseases, but it can also prevent the immune system from killing cancer cells.

Handling

  • Format: Liquid
  • Shipping conditions: Dry ice

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.